All News Caleminder Inc.

Equities

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-.--%

06-20	Clearmind Medicine Signs Agreement to Secure Global Rights for Psychedelic Compound Development, Commercialization for PTSD	MT
02-23	Clearmind Medicine Says Israel Approves Start of Clinical Trial of CMND-100 for Alcohol Use Disorder	MT

Clearmind Medicine Signs Agreement to Secure Global Rights for Psychedelic Compound Development, Commercialization for PTSD	06-20	MT
Clearmind Medicine Says Israel Approves Start of Clinical Trial of CMND-100 for Alcohol Use Disorder	02-23	MT
Clearmind Medicine Receives Patent Approval in China	02-05	MT
Sector Update: Health Care	01-11	MT
Top Midday Decliners	01-11	MT
Top Premarket Decliners	01-11	MT
Top Midday Gainers	01-10	MT
Sector Update: Health Care Stocks Ease Late Afternoon	12-05	MT
Top Midday Gainers	12-05	MT
Top Premarket Gainers	11-30	MT
Sector Update: Health Care Stocks Retreat in Late Afternoon	11-28	MT
Top Midday Gainers	11-28	MT
Clearmind Medicine Closes $2.25 Million Public Offering Exclusive to US	18/09/23	MT
Sector Update: Health Care Stocks Rising Late Afternoon	14/09/23	MT
Sector Update: Health Care Stocks Rising in Afternoon Trading	14/09/23	MT
Sector Update: Health Care	14/09/23	MT
Clearmind Medicine Prices $2.25 Million Public Offering	14/09/23	MT
Sector Update: Health Care Stocks Falling Late Afternoon	06/09/23	MT
Sector Update: Health Care Stocks Down in Afternoon Trading	06/09/23	MT
Clearmind Adds Johns Hopkins University For CMND-100 Trial in Patients With Alcohol Use Disorder	06/09/23	MT

No results for this search